Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / GENOMIC BIOTECH
-
Total 13F shares
-
2,708,855
-
Share change
-
-478,248
-
Total reported value
-
$30,956,644
-
Put/Call ratio
-
150%
-
Price per share
-
$11.38
-
Number of holders
-
59
-
Value change
-
-$5,463,491
-
Number of buys
-
23
-
Number of sells
-
24
Institutional Holders of GLOBAL X FDS - GENOMIC BIOTECH (GNOM) as of Q1 2024
As of 31 Mar 2024,
GLOBAL X FDS - GENOMIC BIOTECH (GNOM) was held by
59 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,708,855 shares.
The largest 10 holders included
One Capital Management, LLC, Mirae Asset Global Investments Co., Ltd., Lido Advisors, LLC, Raymond James Financial Services Advisors, Inc., Portland Global Advisors LLC, IHT Wealth Management, LLC, UBS Group AG, Stratos Wealth Partners, LTD., Sightline Wealth Advisors, LLC, and OPPENHEIMER ASSET MANAGEMENT INC..
This page lists
59
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.